... , N.J. (AP) -- A new type of osteoporosis drug being developed by Merck & Co. increased bone density over two years in postmenopausal women with mild osteoporosis, the company reported Tuesday ...
BOSTON (Reuters) - Merck's popular osteoporosis drug Fosamax and other similar drugs may carry a risk for esophageal cancer, a Food and Drug Administration official said on Wednesday.
Amgen said Tuesday its experimental osteoporosis drug reduced and delayed serious bone complications among patients with advanced breast cancer.
... osteoporosis drug proven to save lives after hip fractures may do so by strengthening the body ... -treated participants. That suggests the drug must work in other ways." The link between osteoporosis and an increased risk ...
... (December 11, 2009) – Low cost osteoporosis drugs are strictly rationed for the under 75s ... guidance," Compston argues, adding that when it comes to osteoporosis, "the fundamental principles of consistent use of the evidence base ...
... density, and on this basis they have begun development of a drug for prevention and treatment of osteoporosis and other bone disorders. The findings ... lead soon to the development of an effective osteoporosis drug. Drugs in use until now have worked to prevent ...
... osteoporosis drug raloxifene may be useful in treating kidney disease in women, suggests a new study led ... of 7,705 post-menopausal women with osteoporosis conducted from 1994 to 1999. The women were randomly ...
... hormone and the only anabolic (meaning it grows bone) osteoporosis drug approved on the market in the United States. Typically, osteoporosis drugs work by preventing bone loss. The study, "Teriparatide and Osseous Regeneration ...
Taking time off from certain osteoporosis drugs may be beneficial to bone health, according to a study conducted ... holiday from bisphosphonates, a popular class of osteoporosis drugs that can cause fractures in the thigh bones and tissue ...
... commonly prescribed osteoporosis drug is associated with a slightly elevated risk of developing the rare, but serious ... considered against the large benefit of these drugs to prevent and treat osteoporosis. The study was funded by the National ...
... are rare among patients who take bisphosphonates.Osteoporosis drugs can definitely strengthen bones. However ... years have uncovered a surprising danger: In some cases, these drugs seem to be breaking bones instead of protecting ...
Women who have used fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to new ...
... killing the jawbones of some people taking drugs that treat osteoporosis. Microbial biofilms, a mix of bacteria ... (bone death) of the jaw in patients who have been taking the drugs for osteoporosis or for treatment from the bone-wasting effects ...
... common medications to prevent or slow the occurrence of osteoporosis, were significantly more likely to experience serious AF ... , clinicians should be more cautious when choosing treatment for osteoporosis and weigh the risks against the benefit of decreased ...
... bone growth, a finding that could lead to new osteoporosis drugs and better bone-building therapies ... , and osteoclasts by resorbing old and brittle bone. Many osteoporosis drugs now target both osteoblasts ...
